Post-market Prospective Clinical Study of Nagor Perle Mammary Implants
NCT: NCT06013514 · RECRUITING
Brief Summary
Patients can undergo breast implant surgery for multiple reasons; cosmetic and reconstructive being the primary indications. In order to confidently state safety and due to strict regulation on medical devices it is important to maintain a record of safety and performance with all medical implants. This study is designed to collect data on a new generation of smooth mammary implants to assess the long term performance and safety data on this type of gel-filled mammary breast implant. The two main complications of breast implants are capsular contracture and rupture; these complications can take years to develop. The study is designed to evaluate the occurrence of these two primary complication as well as other secondary complications over a period of 10 years. Patient follow up will be carried out pre-operatively and post operatively at 12 months and then 3, 5, 8 and 10 years thereafter. The study will be carried out over 10 years to adequately assess complications which may only occur over the lifetime of the device such as systemic complications
Frequently Asked Questions
What is Post-market Prospective Clinical Study of Nagor Perle Mammary Implants?
Post-market Prospective Clinical Study of Nagor Perle Mammary Implants is a clinical trial registered under NCT06013514. Current status: RECRUITING.
What is the status of NCT06013514?
The current status of NCT06013514 (Post-market Prospective Clinical Study of Nagor Perle Mammary Implants) is: RECRUITING.
When did Post-market Prospective Clinical Study of Nagor Perle Mammary Implants start?
Post-market Prospective Clinical Study of Nagor Perle Mammary Implants started on 2024-06-01.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.